A Study of VS-6766 and Defactinib in People With Mesonephric Gynecologic Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge, New Jersey, United States, 07920Contact: Rachel Grisham, MD    646-888-4653      Memorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown, New Jersey, United States, 07748Contact: Rachel Grisham, MD    646-888-4653      Memorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale, New Jersey, United States, 07645Contact: Rachel Grisham, MD    646-888-4653      Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities)Commack, New York, United States, 11725Contact: Rachel Grisham, MD    646-888-4653      Memorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison, New York, United States, 10604Contact: Rachel Grisham, MD    646-888-4653      Memorial Sloan Kettering Cancer CenterNew York, New York, United States, 10065Contact: Rachel Grisham, MD    646-888-4653      Contact: Carol Aghajanian, MD    646-888-4217      Principal Investigator: Rachel Grisham, MD         Memorial Sloan Kettering Nassau (Limited Protocol Activities)Uniondale, New York, United States, 11553Contact: Rachel Grisham, MD    646-888-4653      

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.